-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | 结构式 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| P863803 |
| P,P′-(9,9-二甲基-9H-氧杂蒽-4,5-二基)双[N,N,N′,N′-四乙基-亚膦酸二酰胺], ≥97% P,P′-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis[N,N,N′,N′-tetraethyl-phosphonous diamide], ≥97% |
C31H52N4OP2 | |
| R859680 |
| (2R,2'R,3R,3'R)-4,4'-di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 99% purity,>99% ee (2R,2'R,3R,3'R)-4,4'-di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 99% purity,>99% ee |
C50H44O2P2 | |
| R859587 |
| (+)-1,13-双[二(3,5-二甲基苯基)膦]-(5AR,8AR,14aR)-5a,6,7,8,8a,9-六氢-5-H-[1]苯并吡喃, 98%purity,99%e.e. 1,1'-[(5aR,8aR,14aR)-5a,6,7,8,8a,9-Hexahydro-5H-[1]Benzopyrano[3,2-d]Xanthene-1,13-Diyl]Bis[1,1-di(3,5-Dimethylphenylphosphine, 98%purity,99%e.e. |
C52H54O2P2 | |
| R857210 |
| (11BR)-N-甲基-N-[(R)-1-苯基乙基]-联萘并[2,1-D:1',2'-F][1,3,2]二氧膦杂-4-胺, 97% R-N-Methyl-N-[(1R)-1-phenylethyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-aMine, 97% |
C29H24NO2P | |
| S803272 |
| (2S, 4S)-4-二苯基膦-2-(二苯基膦甲基)-1-特丁氧羰基吡咯烷, 97% (2S,4S)-1-tert-Butoxycarbonyl-4-diphenylphosphino-2-(diphenylphosphinomethyl)pyrrolidine, 97% |
C34H37NO2P2 | |
| S802646 |
| (S)-(-)-2,2'-双(二苯膦基)-1,1'-联萘, 98% (S)-(-)-BINAP, 98% |
C44H32P2 | |
| R802402 |
| (R)-(+)-2,2'-双(二苯膦基)-1,1'-联萘, 98% (R)-(+)-BINAP, 98% |
C44H32P2 | |
| R854272 |
| (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,99%e.e. (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,99%e.e. |
C29H21N2O8P | |
| S854246 |
| (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥98%,99%e.e. (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥98%,99%e.e. |
C56H45O4P | |
| S853906 |
| (4S)-2-[(1S)-7'-(Diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-4,5-dihydro-4-(phenylmethyl)oxazole, ≥98%,≥99% e.e. (4S)-2-[(1S)-7'-(Diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-4,5-dihydro-4-(phenylmethyl)oxazole, ≥98%,≥99% e.e. |
C39H34NOP | |
| R853905 |
| 1,1'-[(1R)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diyl]bis[1,1-bis(3,5-dimethylphenyl)phosphine], 98% 1,1'-[(1R)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diyl]bis[1,1-bis(3,5-dimethylphenyl)phosphine], 98% |
C49H50P2 | |
| R853893 |
| 1,1'-[(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene-1,13-diyl]bis[1,1-di(4-methylphenyl)phosphine], ≥95%,≥99%e.e. 1,1'-[(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene-1,13-diyl]bis[1,1-di(4-methylphenyl)phosphine], ≥95%,≥99%e.e. |
C48H46O2P2 | |
| R835576 |
| (R)-1-((Sp)-2-[双(4-甲氧基-3,5-二甲苯基)膦]二茂铁基)-乙基双(2-甲苯基)膦, 97% (R)-1-((Sp)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl)-ethylbis(2-methylphenyl)phosphine, 97% |
C44H48FeO2P2 | |
| S835574 |
| (S)-1-((Rp)-2-[双(4-甲氧基-3,5-二甲苯基)膦]二茂铁基)乙基二叔丁基膦, 98% (S)-1-((Rp)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl)ethyldi-tert-butylphosphine, 98% |
C38H52FeO2P2 | |
| R835558 |
| (R)-1-(SP)-2-[双[3,5-双(三氟甲基)苯基]膦基]二茂铁基乙基二(3,5-二甲苯基)膦, 97% (R)-1-(SP)-2-[Bis[3,5-bis(trifluoromethyl)phenyl]phosphino]ferrocenylethyldi(3,5-xylyl)phosphine, 97% |
C44H36F12FeP2 | |
| B828409 |
| 4,5-双(二环己基膦)-二苯并吡喃衍生物, 98% 4,5-Bis(dicyclohexylphosphino)-9, 98% |
C39H56OP2 | |
| A849354 |
| (4-氨基-1-羟基丁烷-1,1-二基)二磷酸, 98% Alendronic Acid, 98% |
C4H13NO7P2 | |
| R822233 |
| 5,5'-双[二(3,5-二甲苯基)磷酰]-4,4'-二-1,3-氧代联苯, >95.0%(HPLC) (R)-(+)-5,5'-Bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole, >95.0%(HPLC) |
C46H44O4P2 | |
| S818240 |
| (S,S)-双[(2-甲氧基苯基)苯基磷]乙烷, 97% (S,S)-DIPAMP, 97% |
C28H28P2O2 | |
| R820100 |
| (R)-(+)-2,2',6,6'-四甲氧基-4,4'-双(二苯基膦)-3,3'-联吡啶, 97% (R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, 97% |
C38H34N2O4P2 |
